Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma.
Saved in:
| Title: | Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma. |
|---|---|
| Authors: | Lee JH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Kim SH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Kim HR; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Min CK; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Lee JJ; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea., Shin HJ; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea., Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea., Lee JY; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Moon JH; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Kyungpook National University, 130, Dongduk-Ro, Jung-Gu, Daegu, 41944, Republic of Korea. jhmoon@knu.ac.kr., Kim K; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 81, Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. kihyunkimk@gmail.com. |
| Source: | International journal of hematology [Int J Hematol] 2023 Feb; Vol. 117 (2), pp. 225-235. Date of Electronic Publication: 2022 Nov 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36369635 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SH%22">Kim SH</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HR%22">Kim HR</searchLink>; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Min+CK%22">Min CK</searchLink>; Department of Hematology, Seoul St. Mary's Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JJ%22">Lee JJ</searchLink>; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+HJ%22">Shin HJ</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+JC%22">Jo JC</searchLink>; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Moon+JH%22">Moon JH</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Kyungpook National University, 130, Dongduk-Ro, Jung-Gu, Daegu, 41944, Republic of Korea. jhmoon@knu.ac.kr.<br /><searchLink fieldCode="AU" term="%22Kim+K%22">Kim K</searchLink>; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, 81, Irwon-Ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. kihyunkimk@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2023 Feb; Vol. 117 (2), pp. 225-235. <i>Date of Electronic Publication: </i>2022 Nov 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36369635 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12185-022-03479-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 225 Titles: – TitleFull: Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lee JH – PersonEntity: Name: NameFull: Kim SH – PersonEntity: Name: NameFull: Kim HR – PersonEntity: Name: NameFull: Min CK – PersonEntity: Name: NameFull: Lee JJ – PersonEntity: Name: NameFull: Shin HJ – PersonEntity: Name: NameFull: Jo JC – PersonEntity: Name: NameFull: Lee JY – PersonEntity: Name: NameFull: Moon JH – PersonEntity: Name: NameFull: Kim K IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2023 Feb Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1865-3774 Numbering: – Type: volume Value: 117 – Type: issue Value: 2 Titles: – TitleFull: International journal of hematology Type: main |
| ResultId | 1 |